Repair or Replace: What Are We Learning From Real-World Studies?
Published: 02 December 2022
-
Views:
5277 -
Likes:
7
-
Views:
5277 -
Likes:
7
-
Up Next
-
5m 22sPart 1 | Session 3 Round-up of Real-World Data in Tricuspid Regurgitation: Philipp Lurz
-
7m 44s
-
4m 11sPart 1 | Session 5 Patient Selection in Tricuspid Regurgitation: Marta Sitges
-
4m 18sPart 1 | Session 1 Why We Need Real-World Data in Valve Treatment?: Anita Asgar Anita W Asgar, Paolo Denti, Marta Sitges, Maurizio Taramasso, Philipp Lurz
Overview
What are real-world studies telling us about selecting between repair or replace strategies for leaky valves? In this series of videos, we bring you up to date with how the dynamic is changing in favour of transcatheter approaches for a great number of patients, and provide some practical guidance for patient selection in both tricuspid and mitral regurgitation. We also explore how a rapidly accumulating body of real-world evidence is starting to shed light on new patient groups that stand to benefit from transcatheter strategies, and seek expert views from both a surgical and interventional perspective on the future success of these treatments.
Filmed following data released at PCR London Valves 2022, our faculty examine some of the latest real-world data on mitral and tricuspid regurgitation and put this data into context for practitioners.
Learning Objectives
- Describe the value of real-world data in the treatment of mitral and tricuspid regurgitation
- Review how patient selection for repair or replacement strategies may change in the near future
- Identify patient groups in whom transcatheter repair and replacement strategies may be preferable over surgical approaches
- Understand the value of surgical teams for transcatheter valve interventions
- Recall the latest real-world evidence on transcatheter repair and replacement treatments for tricuspid and mitral regurgitation
Target Audience
- Interventional Cardiologists
- Cardiac Surgeons
- Heart Failure Specialists
- General Cardiologists
More from this programme
Part 1
Repair or Replace: What Are We Learning From Real-World Studies?
Faculty Biographies
Paolo Denti
Paolo Denti is responsible for the Functional Department of Transcatheter Therapy of Structural Heart Disease in the Department of Cardiac Surgery at the IRCCS Ospedale San Raffaele in Milan under the supervision of Professor Alessandro Castiglioni.
After graduating in Medicine and Surgery in 2004 with top marks from the University of Vita-Salute San Raffaele, he completed his specialization in cardiac surgery in 2008 at the same university.
He is mainly engaged in the treatment of diseases of the aortic, mitral and tricuspid heart valves (insufficiency and stenosis) and coronary surgery.